Europe Endoscopic Retrograde Cholangiopancreatography Market: Industry Analysis and Forecast (2024-2030)

Europe Endoscopic Retrograde Cholangiopancreatography Market Definition/Overview:

Europe Endoscopic Retrograde Cholangiopancreatography Market is projected to grow at CAGR of xx% during the forecast period, due to increasing rate of pancreatic ailments in the region. Gallstones and other disorders are causing an increase in the prevalence of common bile duct stones. Gallstone-related bile duct stone problems that necessitate ERCP procedures for stone extraction are becoming common norm these days in the European region. For successful and safe treatment of such bile duct stone diseases, minimally invasive methods are required and this is where Endoscopic Retrograde Cholangiopancreatography comes into play. Diagnosed common bile duct stones, for example, were predicted to be present in 10-20 percent of individuals with symptomatic gallstones in patients across the European region.

 

 

To get more Insights: Request Free Sample Report

 

Europe Endoscopic Retrograde Cholangiopancreatography Market Dynamics:

Due to technological advancements in endoscopes that may be used to identify diseases and an increase in the incidence rate of diseases that require endoscopy devices, the endoscopy devices market in Europe is predicted to grow significantly over the forecast period. Other factors, such as the use of innovative and revolutionary endoscopic equipment, such as capsule endoscopes, robot-assisted endoscopy, and ultra-high-definition visualisation systems, are expected to fuel the growth of the endoscopy device market. Furthermore, favourable FDA approvals and return policies for endoscopy equipment in developed countries, improved patient choice for minimally invasive surgery, faster recovery times, and reduced postoperative complications all contribute to the European region's endoscopic device market growth. The lack of experienced physicians and endoscopists, the high cost of advanced endoscopic devices, and infections caused by a few endoscopes, such as excessive bleeding is always a risk, and a rip in the oesophagus or stomach wall is a possibility on rare occasions, are expected to stifle the growth of the European endoscopy devices market. Furthermore, an increase in the number of market competitors and the availability of alternative items may stymie market growth.

 

The German market for Endoscopic Retrograde Cholangiopancreatography has the largest share in Europe, followed by the United Kingdom and France. Over one-fifth of Europe's population, or 20.6 percent, is 65 or older. The proportion of people aged 80 and more in Europe's population is expected to rise by two-thirds, from 5.9% to 14.6 percent. Italy once again has the highest proportion of elderly people in Europe. The population over the age of 62 accounted for 22.8 percent of the total. The growing demand for less intrusive treatments, high incidence of chronic illnesses, increased awareness, and technological advancements all contribute to the German endoscopic devices market's growth. Furthermore, orthopaedic surgery is more prevalent among the elderly. As a result, Germany's senior population is substantial and expected to continue to increase in the future. Furthermore, the region's market growth is expected to be aided by increased demand for non-invasive procedures.

 

The rising desire for minimally invasive treatments in operations, on the other hand, is propelling the endoscopic devices market in the United Kingdom forward. Furthermore, technological advancements, an ageing population, lower healthcare costs, and improved patient quality of life are driving endoscopic device market expansion in the United Kingdom. Furthermore, the United Kingdom is more likely to contribute to regional market growth in Europe. The availability of modern healthcare facilities, the expanding elderly population, and technological improvements in the healthcare sector are projected to fuel market growth.

 

In terms of market restraints, one of the issues with Endoscopic Retrograde Cholangiopancreatography is that it has been observed to have negative effects on the endoscopists. Work-related musculoskeletal disorders have become more prominent as interventional GI endoscopy has become more complicated and examination times have increased. Data on work-related health stress in German endoscopists, on the other hand, is scarce. The top German associations for gastroenterology and endoscopy circulated the survey online. In total, 151 professional German endoscopists took part in the study. In the major demographic surveys in Europe, the median prevalence of gallstone disease ranged from 5.9% to 21.9 percent, 8–20, with the greatest rates in Norway (21.9%) and former East Germany (19.7%), and the lowest rates in Italy (Chianciano 5.9 % and Sirmione 6.9 %) The study group was mostly made up of high-volume endoscopists when it came to the average number of endoscopic procedures performed each week. Additionally high prices of Endoscopic Retrograde Cholangiopancreatography equipment and procedures are one of the most significant market restraints.

 

Europe Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis:

On the basis of product type, Endotherapy devices are projected to dominate the market in 2030 due to growth of gastrointestinal conditions and minimally invasive surgeries. Additionally, the reason for significant growth due to rise in prevalence of choledocholithiasis, gallbladder stones, pancreatitis, and other bile duct & pancreatic duct diseases. Further, by Endotherapy devices, the stents and sphincterotome segments held the largest share and is estimated to keep growing at a significant rate during the forecast period. Additionally, the imaging devices market in Europe region is also projected to witness significant growth rate due to increase in the geriatric population and the rising prevalence of chronic diseases, technological advancement in imaging modalities, and the rising adoption of medical imaging devices.

 

On the basis of end user, the Endoscopic Retrograde Cholangiopancreatography Market in Europe is dominated by hospitals and clinics. However, Ambulatory surgical centres are projected to grow at a significant rate during the forecast period in the European region. This is because in hospital surgery has become very costly and to address the cost issue ASCs (Ambulatory Surgical Services) are taking place of traditional ones. The hospital and clinic structure will still hold major market share during the forecast period. This is largely due to the fact that majority of volume consumption comes from hospital and clinics across the Europe region. The testing and diagnosis are also mostly in-house when it comes to hospitals in the Europe region. All these factors contribute significantly to the growth of Endoscopic Retrograde Cholangiopancreatography Market

 

 

On the basis of application, Pancreatic Sphincterotomy is projected to dominate the Endoscopic Retrograde Cholangiopancreatography Market due to increase in medical issues related to gall bladder stones, pancreatic cancer and Gallstones. Additionally, the growing geriatric population in the Europe region has a demand for endoscopies due to increase in biliary disorders.    

 

The objective of the report is to present a comprehensive analysis of the Europe Endoscopic Retrograde Cholangiopancreatography market to the stakeholders in the industry. The report provides trends that are most dominant in the Europe Endoscopic Retrograde Cholangiopancreatography market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the Europe Endoscopic Retrograde Cholangiopancreatography Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

 

The qualitative and quantitative data provided in the Europe Endoscopic Retrograde Cholangiopancreatography market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Europe Endoscopic Retrograde Cholangiopancreatography market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the Europe Endoscopic Retrograde Cholangiopancreatography market.

 

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Europe Endoscopic Retrograde Cholangiopancreatography market. The report also analyses if the Europe Endoscopic Retrograde Cholangiopancreatography market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Europe Endoscopic Retrograde Cholangiopancreatography market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Europe Endoscopic Retrograde Cholangiopancreatography market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Europe Endoscopic Retrograde Cholangiopancreatography market is aided by legal factors.

 

Europe Endoscopic Retrograde Cholangiopancreatography Market Scope:

Europe Endoscopic Retrograde Cholangiopancreatography Market
Market Size in 2023	USD 323.87 Mn.
Market Size in 2030	USD 540.83 Mn.
CAGR (2024-2030)	7.6%
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segment Scope	By Product Type Endoscopes Endotherapy Devices Imaging Devices Energy Devices
	By Application Biliary Sphincterotomy Biliary Dilatation Biliary Stenting Pancreatic Sphincterotomy Pancreatic Duct Dilatation Pancreatic Duct Stenting
	By End-user Hospitals & Clinics Ambulatory Surgery Centers Others
Country Scope	UK  France Germany Italy  Spain  Sweden Austria and Rest of Europe

 

Europe Endoscopic Retrograde Cholangiopancreatography Key Players:  

• FUJIFILM Healthcare Austria GesmbH (Austria)
• Olympus Europa (Germany)
• Stryker Corporation (Netherlands)
• Ethicon Endo Surgery (Germany)
• Karl Storz GmbH (Germany)
• Boston Scientific (France)
• Medtronic Ltd (UK)
• Smith & Nephew AB (Sweden)
• Merit Medical Nederland B.V. (Netherlands)
• Sterris Intrument Management Services (UK)